When clinical trials fail to represent patients: implications for schizophrenia guidelines.
Saved in:
| Title: | When clinical trials fail to represent patients: implications for schizophrenia guidelines. |
|---|---|
| Authors: | Llorca-Bofí V; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS); Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III (CIBERSAM), Barcelona; University of Barcelona, Barcelona, Catalonia, Spain., Bioque M; Barcelona Clínic Schizophrenia Unit (BCSU), Neuroscience Institute, Hospital Clínic de Barcelona, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS); Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III (CIBERSAM), Barcelona; University of Barcelona, Barcelona, Catalonia, Spain. Electronic address: mbioque@clinic.cat. |
| Source: | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology [Eur Neuropsychopharmacol] 2026 Sep; Vol. 110, pp. 112856. Date of Electronic Publication: 2026 Apr 29. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9111390 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7862 (Electronic) Linking ISSN: 0924977X NLM ISO Abbreviation: Eur Neuropsychopharmacol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1873-7862 |
|---|---|
| DOI: | 10.1016/j.euroneuro.2026.112856 |
